Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sulfasalazine"" wg kryterium: Temat


Tytuł :
Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry.
Autorzy :
Choi J; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Park MH; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Shin SH; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Byeon JJ; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Lee BI; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Park Y; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Shin YG; Institute of Drug Research and Development, College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Feb 22; Vol. 26 (4). Date of Electronic Publication: 2021 Feb 22.
Typ publikacji :
Journal Article
MeSH Terms :
Brain/*metabolism
Sulfasalazine/*analysis
Sulfasalazine/*metabolism
Animals ; Male ; Mass Spectrometry ; Mice ; Mice, Inbred ICR ; Sulfasalazine/pharmacokinetics ; Time Factors
Czasopismo naukowe
Tytuł :
BiVO 4 /WO 3 nano-composite: characterization and designing the experiments in photodegradation of sulfasalazine.
Autorzy :
Omrani N; Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.; Young Researchers and Elite Club, Shahreza Branch, Islamic Azad University, Shahreza, Iran.
Nezamzadeh-Ejhieh A; Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran. .; Young Researchers and Elite Club, Shahreza Branch, Islamic Azad University, Shahreza, Iran. .; Razi Chemistry Research Center (RCRC), Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran. .
Pokaż więcej
Źródło :
Environmental science and pollution research international [Environ Sci Pollut Res Int] 2020 Dec; Vol. 27 (35), pp. 44292-44305. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article
MeSH Terms :
Sulfasalazine*
Vanadates*
Bismuth ; Catalysis ; Photolysis
Czasopismo naukowe
Tytuł :
Erythema nodosum treated by sulfasalazine in a pregnant patient.
Autorzy :
Mohammed A; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Rahnama-Moghadam S; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14288. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Letter
MeSH Terms :
Erythema Nodosum*/diagnosis
Erythema Nodosum*/drug therapy
Sulfasalazine*/adverse effects
Diagnosis, Differential ; Female ; Humans ; Pregnancy
Opinia redakcyjna
Tytuł :
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Autorzy :
Murray A; Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada.
Nguyen TM; Robarts Clinical Trials, London, Canada.
Parker CE; Robarts Clinical Trials, London, Canada.
Feagan BG; Robarts Clinical Trials, London, Canada.; Department of Medicine, University of Western Ontario, London, Canada.; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Canada.
MacDonald JK; Department of Medicine, University of Western Ontario, London, Canada.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Aug 12; Vol. 8. Cochrane AN: CD000543. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage
Colitis, Ulcerative/*drug therapy
Mesalamine/*administration & dosage
Sulfasalazine/*administration & dosage
Administration, Oral ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Bias ; Drug Administration Schedule ; Humans ; Induction Chemotherapy/methods ; Mesalamine/adverse effects ; Patient Dropouts/statistics & numerical data ; Placebos/therapeutic use ; Randomized Controlled Trials as Topic ; Remission Induction ; Sulfasalazine/adverse effects ; Treatment Failure
Czasopismo naukowe
Tytuł :
[DRESS syndrome induced by sulfasalazine. Report of one case].
Autorzy :
Arce E; Departamento de Medicina Interna, Hospital Clínico Universidad de Chile, Santiago, Chile.
Quera R; Clínica Las Condes, Santiago, Chile.
Flores L; Clínica Las Condes, Santiago, Chile.
Blamey R; Clínica Las Condes, Santiago, Chile.
Pokaż więcej
Transliterated Title :
Síndrome de DRESS inducido por sulfasalazina. ¿Consideramos esta reacción adversa grave al indicar el fármaco? Caso clínico.
Źródło :
Revista medica de Chile [Rev Med Chil] 2020 Aug; Vol. 148 (8), pp. 1213-1218.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antirheumatic Agents*/adverse effects
Drug Hypersensitivity Syndrome*/diagnosis
Drug Hypersensitivity Syndrome*/etiology
Eosinophilia*/chemically induced
Sulfasalazine*/adverse effects
Adrenal Cortex Hormones ; Female ; Humans ; Infliximab ; Young Adult
Czasopismo naukowe
Tytuł :
System X c Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine. Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine.
Autorzy :
Nehser M; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Dark J; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Schweitzer D; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Campbell M; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Zwicker J; Deciphera Pharmaceuticals, Lawrence, KA, 66044, USA.
Hitt DM; Chemistry Department, Carroll College, Helena, MT, 56925, USA.
Little H; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Diaz-Correa A; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Holley DC; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Patel SA; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Thompson CM; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA.
Bridges RJ; Department of Biomedical and Pharmaceutical Science, Center for Structural and Functional Neuroscience, Skaggs School of Pharmacy, University of Montana, Missoula, MT, 59812, USA. .
Pokaż więcej
Źródło :
Neurochemical research [Neurochem Res] 2020 Jun; Vol. 45 (6), pp. 1375-1386. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji :
Journal Article
MeSH Terms :
Amino Acid Transport System y+/*antagonists & inhibitors
Amino Acid Transport System y+/*metabolism
Sulfasalazine/*analogs & derivatives
Sulfasalazine/*pharmacology
Amino Acid Transport System y+/chemistry ; Anti-Inflammatory Agents, Non-Steroidal/chemistry ; Anti-Inflammatory Agents, Non-Steroidal/metabolism ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Antiporters/antagonists & inhibitors ; Antiporters/chemistry ; Antiporters/metabolism ; Binding Sites/drug effects ; Binding Sites/physiology ; Cell Line, Tumor ; Humans ; Molecular Docking Simulation/methods ; Protein Structure, Secondary ; Protein Structure, Tertiary ; Sulfasalazine/metabolism
Czasopismo naukowe
Tytuł :
Preparation of Fe@Fe 2 O 3 /3D graphene composite cathode for electrochemical removal of sulfasalazine.
Autorzy :
Amali S; Research Laboratory of Environmental Remediation, Department of Applied Chemistry, University of Tabriz, 51666-16471, Tabriz, Iran. Electronic address: .
Zarei M; Research Laboratory of Environmental Remediation, Department of Applied Chemistry, University of Tabriz, 51666-16471, Tabriz, Iran. Electronic address: .
Ebratkhahan M; Research Laboratory of Environmental Remediation, Department of Applied Chemistry, University of Tabriz, 51666-16471, Tabriz, Iran. Electronic address: .
Khataee A; Research Laboratory of Advanced Water and Wastewater Treatment Processes, Department of Applied Chemistry, Faculty of Chemistry, University of Tabriz, 51666-16471, Tabriz, Iran; Department of Environmental Engineering, Gebze Technical University, 41400, Gebze, Turkey. Electronic address: .
Pokaż więcej
Źródło :
Chemosphere [Chemosphere] 2021 Jun; Vol. 273, pp. 128581. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Graphite*
Water Pollutants, Chemical*
Electrodes ; Hydrogen Peroxide ; Sulfasalazine
Czasopismo naukowe
Tytuł :
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Autorzy :
Ganapati A; Department of Clinical Immunology and Rheumatology, Christian Medical College & Hospital, Ida Scudder Road, Vellore, Tamil Nadu, 632004, India.
Gowri M; Department of Biostatistics, Christian Medical College, Vellore, India.
Antonisamy B; Department of Biostatistics, Christian Medical College, Vellore, India.
Danda D; Department of Clinical Immunology and Rheumatology, Christian Medical College & Hospital, Ida Scudder Road, Vellore, Tamil Nadu, 632004, India. .
Pokaż więcej
Źródło :
Clinical rheumatology [Clin Rheumatol] 2021 May; Vol. 40 (5), pp. 1871-1879. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article
MeSH Terms :
Antirheumatic Agents*/therapeutic use
Spondylarthritis*/drug therapy
Spondylitis, Ankylosing*/drug therapy
Cohort Studies ; Humans ; Methotrexate/therapeutic use ; Prospective Studies ; Sulfasalazine/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
Autorzy :
Lillegraven S; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Paulshus Sundlisæter N; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Aga AB; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Sexton J; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Olsen IC; Clinical Trial Unit, Oslo University Hospital, Oslo, Norway.
Fremstad H; Department of Rheumatology, Ålesund Hospital, Helse Møre og Romsdal HF, Ålesund, Norway.
Spada C; Revmatismesykehuset AS, Lillehammer, Norway.
Madland TM; Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
Høili CA; Department of Rheumatology, Hospital Østfold HF, Moss, Norway.
Bakland G; Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway.
Lexberg Å; Department of Rheumatology, Drammen Hospital, Vestre Viken HF, Drammen, Norway.
Hansen IJW; Department of Rheumatology, Sørlandet Hospital HF, Kristiansand, Norway.
Hansen IM; Department of Rheumatology, Helgelandssykehuset Mo i Rana, Mo i Rana, Norway.
Haukeland H; Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway.
Ljoså MA; Department of Rheumatology, Ålesund Hospital, Helse Møre og Romsdal HF, Ålesund, Norway.
Moholt E; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Uhlig T; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Solomon DH; Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts.
van der Heijde D; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands.
Kvien TK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 May 04; Vol. 325 (17), pp. 1755-1764.
Typ publikacji :
Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Symptom Flare Up*
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*administration & dosage
Adult ; Aged ; Antirheumatic Agents/adverse effects ; Arthritis, Rheumatoid/diagnostic imaging ; Arthritis, Rheumatoid/pathology ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Leflunomide/administration & dosage ; Male ; Methotrexate/adverse effects ; Middle Aged ; Radiography ; Sulfasalazine/administration & dosage ; Ultrasonography
Czasopismo naukowe
Tytuł :
Therapeutic effects of combination of platelet lysate and sulfasalazine administration in TNBS-induced colitis in rat.
Autorzy :
Yousefi-Ahmadipour A; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Ebrahimi-Barough S; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Niknia S; Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Allahverdi A; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Mirzahosseini-Pourranjbar A; Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Tashakori M; Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Khajouee Ravari S; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Asadi F; Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Heidari Barchi Nezhad R; Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Lotfibakhshaiesh N; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Mirzaei MR; Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 May; Vol. 125, pp. 109949. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Platelets/*chemistry
Colitis/*therapy
Inflammatory Bowel Diseases/*therapy
Sulfasalazine/*pharmacology
Animals ; Apoptosis/drug effects ; Colitis/physiopathology ; Combined Modality Therapy ; Cytokines/metabolism ; Disease Models, Animal ; Gastrointestinal Agents/administration & dosage ; Gastrointestinal Agents/pharmacology ; Inflammatory Bowel Diseases/physiopathology ; Male ; NF-kappa B/metabolism ; Rats ; Rats, Wistar ; Signal Transduction/drug effects ; Sulfasalazine/administration & dosage ; Treatment Outcome ; Trinitrobenzenesulfonic Acid
Czasopismo naukowe
Tytuł :
Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis.
Autorzy :
Nozaki Y; Department of Hematology and Rheumatology, School of Medicine, Kindai University, Osaka, Japan.
Inoue A; Department of Hematology and Rheumatology, School of Medicine, Kindai University, Osaka, Japan.
Kinoshita K; Department of Hematology and Rheumatology, School of Medicine, Kindai University, Osaka, Japan.
Funauchi M; Department of Hematology and Rheumatology, School of Medicine, Kindai University, Osaka, Japan.
Matsumura I; Department of Hematology and Rheumatology, School of Medicine, Kindai University, Osaka, Japan.
Pokaż więcej
Źródło :
Modern rheumatology [Mod Rheumatol] 2020 Mar; Vol. 30 (2), pp. 249-258. Date of Electronic Publication: 2019 Mar 04.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Chromones/*therapeutic use
Sulfasalazine/*therapeutic use
Sulfonamides/*therapeutic use
Adult ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/adverse effects ; Chromones/administration & dosage ; Chromones/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Sulfasalazine/administration & dosage ; Sulfasalazine/adverse effects ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects
Czasopismo naukowe
Tytuł :
The X c inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism. inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism.
Autorzy :
Zheng Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Luo G; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Shi X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Long Y; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Shen W; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Li Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. .
Zhang X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło :
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2020 Feb; Vol. 43 (1), pp. 95-106. Date of Electronic Publication: 2019 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Ascorbic Acid/*therapeutic use
Glutathione/*metabolism
Prostatic Neoplasms/*drug therapy
Sulfasalazine/*therapeutic use
Acetylcysteine/pharmacology ; Amino Acid Transport System y+/antagonists & inhibitors ; Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antioxidants/pharmacology ; Apoptosis/drug effects ; Ascorbic Acid/metabolism ; Ascorbic Acid/pharmacology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Drug Synergism ; Humans ; Immunohistochemistry ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Prostatic Neoplasms/enzymology ; Prostatic Neoplasms/metabolism ; Reactive Oxygen Species/metabolism ; Sulfasalazine/pharmacology ; Transplantation, Heterologous
Czasopismo naukowe
Tytuł :
The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis.
Autorzy :
Yee J; Division of Life and Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Kim SM; College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Han JM; College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.; Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Lee N; Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Yoon HY; Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Gwak HS; College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea. .; Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Feb 27; Vol. 10 (1), pp. 3658. Date of Electronic Publication: 2020 Feb 27.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Polymorphism, Genetic*
Arylamine N-Acetyltransferase/*genetics
Sulfasalazine/*adverse effects
Humans ; Sulfasalazine/therapeutic use
Czasopismo naukowe
Tytuł :
The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study).
Autorzy :
Zhao J; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, 100034, China.
Zhou W; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, 100034, China.
Wu Y; Peking University Clinical Research Institute (PUCRI), Beijing, 100083, China.
Ji P; Peking University Clinical Research Institute (PUCRI), Beijing, 100083, China.
Yang L; Peking University School of Public Health, Beijing, 100083, China.
Yan X; Peking University Clinical Research Institute (PUCRI), Beijing, 100083, China.
Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, 100034, China. .
Pokaż więcej
Źródło :
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2021 Mar 04; Vol. 21 (1), pp. 83. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Cost-Benefit Analysis ; Drug Therapy, Combination ; Humans ; Hydroxychloroquine/therapeutic use ; Methotrexate/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Quality of Life ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Sulfasalazine/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
COVID-19 in IBD: The experience of a single tertiary IBD center.
Autorzy :
Rizzello F; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Calabrese C; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Salice M; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Calandrini L; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Privitera H; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Melotti L; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Peruzzi G; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Dussias N; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Belluzzi A; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Scaioli E; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Decorato A; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Siniscalchi A; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Filippone E; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Laureti S; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Rottoli M; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Poggioli G; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Gionchetti P; Centro di Riferimento Regionale Malattie Infiammatorie Croniche Intestinali, DIMEC Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna, Italy. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Mar; Vol. 53 (3), pp. 271-276. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19/*epidemiology
Colitis, Ulcerative/*epidemiology
Crohn Disease/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/therapeutic use ; Biological Products/therapeutic use ; COVID-19/physiopathology ; Colitis, Ulcerative/drug therapy ; Colitis, Ulcerative/physiopathology ; Crohn Disease/drug therapy ; Crohn Disease/physiopathology ; Deprescriptions ; Female ; Gastrointestinal Agents/therapeutic use ; Hospitalization/statistics & numerical data ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Inflammatory Bowel Diseases/epidemiology ; Inflammatory Bowel Diseases/physiopathology ; Italy/epidemiology ; Male ; Mesalamine/therapeutic use ; Middle Aged ; SARS-CoV-2 ; Sulfasalazine/therapeutic use ; Tertiary Care Centers ; Time-to-Treatment ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil.
Autorzy :
Amekyeh H; Department of Pharmaceutics, School of Pharmacy, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Billa N; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Feb 09; Vol. 26 (4). Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article
MeSH Terms :
Cacao/*chemistry
Drug Carriers/*chemistry
Lipids/*chemistry
Nanoparticles/*chemistry
Pharmaceutical Preparations/*chemistry
Plant Oils/*chemistry
Waxes/*chemistry
Acetaminophen/chemistry ; Amphotericin B/chemistry ; Drug Compounding ; Freeze Drying ; Hydrophobic and Hydrophilic Interactions ; Sulfasalazine/chemistry
Czasopismo naukowe
Tytuł :
First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine.
Autorzy :
Jacobs ME; Department of Rheumatology and Clinical Immunology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Pouw JN; Department of Rheumatology and Clinical Immunology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Welsing P; Department of Rheumatology and Clinical Immunology, Utrecht, the Netherlands.
Radstake TRDJ; Department of Rheumatology and Clinical Immunology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Leijten EFA; Department of Rheumatology and Clinical Immunology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Feb 01; Vol. 60 (2), pp. 780-784.
Typ publikacji :
Journal Article
MeSH Terms :
Arthritis, Psoriatic/*drug therapy
Methotrexate/*therapeutic use
Sulfasalazine/*therapeutic use
Antirheumatic Agents/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Failure ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
Autorzy :
Brenner EJ; Department of Pediatric Gastroenterology, University of North Carolina, Chapel Hill, North Carolina. Electronic address: .
Pigneur B; Hôpital Necker Enfants Malades, APHP, Université de Paris, Paris, France.
Focht G; Juliet Keidan Institute of Pediatric Gastroenterology, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Zhang X; Department of Gastroenterology, University of North Carolina, Chapel Hill, North Carolina.
Ungaro RC; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Turner D; Juliet Keidan Institute of Pediatric Gastroenterology, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Kappelman MD; Department of Pediatric Gastroenterology, University of North Carolina, Chapel Hill, North Carolina.
Ruemmele FM; Hôpital Necker Enfants Malades, APHP, Université de Paris, Paris, France.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Feb; Vol. 19 (2), pp. 394-396.e5. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
COVID-19/*physiopathology
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Systemic Inflammatory Response Syndrome/*physiopathology
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adolescent ; Ambulatory Care ; COVID-19/epidemiology ; COVID-19/therapy ; Child ; Colitis, Ulcerative/epidemiology ; Comorbidity ; Crohn Disease/epidemiology ; Female ; Hospitalization ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Inflammatory Bowel Diseases/epidemiology ; Male ; Mesalamine/therapeutic use ; SARS-CoV-2 ; Sulfasalazine/therapeutic use ; Systemic Inflammatory Response Syndrome/epidemiology ; Systemic Inflammatory Response Syndrome/therapy
SCR Disease Name :
Pediatric Crohn's disease; Pediatric ulcerative colitis; pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
[DRESS syndrome simulating coronavirus 2019-NcoV disease].
Autorzy :
Novo de Matos J; Medicina de Familia, Centro de Salud Canillejas, Madrid, España.
Redondo Sendino A; Medicina de Familia, Centro de Salud Canillejas, Madrid, España. Electronic address: .
Pozo Teruel A; Medicina de Familia, Centro de Salud Canillejas, Madrid, España.
Redondo Sendino JI; Farmacia San José, Las Palmas de Gran Canaria, España.
Pokaż więcej
Transliterated Title :
Síndrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.
Źródło :
Semergen [Semergen] 2021 Jan-Feb; Vol. 47 (1), pp. 56-58. Date of Electronic Publication: 2020 May 21.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Diagnostic Errors*
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
COVID-19/*diagnosis
Drug Hypersensitivity Syndrome/*diagnosis
Sulfasalazine/*adverse effects
Adolescent ; Diagnosis, Differential ; Drug Hypersensitivity Syndrome/etiology ; Humans ; Male
Raport
Tytuł :
Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?
Autorzy :
Balconi SN; Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, Brazil.
Lopes NT; Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, Brazil.
Luzzatto L; Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, Brazil.
Bonamigo RR; Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, Brazil.; Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, Brazil.; Medical School of Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Pokaż więcej
Źródło :
International journal of dermatology [Int J Dermatol] 2021 Jan; Vol. 60 (1), pp. 125-126. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
COVID-19/*complications
Drug Hypersensitivity Syndrome/*etiology
Drug Hypersensitivity Syndrome/*virology
SARS-CoV-2/*isolation & purification
Sulfasalazine/*adverse effects
Female ; Humans ; Young Adult
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies